MMSI Quote, Financials, Valuation and Earnings

ICU Medical, Inc. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of -0.63%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat ICU Medical, Inc.'s return on equity of -0.36%.

Merit Medical Systems, Inc. has a consensus price target of $104.00, signalling upside risk potential of 28.25%. On the other hand ICU Medical, Inc. has an analysts' consensus of $180.83 which suggests that it could grow by 20.64%. Given that Merit Medical Systems, Inc. has higher upside potential than ICU Medical, Inc., analysts believe Merit Medical Systems, Inc. is more attractive than ICU Medical, Inc..

Merit Medical Systems, Inc. has a beta of 0.617, which suggesting that the stock is 38.251% less volatile than S&P 500. In comparison ICU Medical, Inc. has a beta of 0.799, suggesting its less volatile than the S&P 500 by 20.087%.

Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ICU Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. ICU Medical, Inc. pays out -- of its earnings as a dividend.

Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are smaller than ICU Medical, Inc. quarterly revenues of $537.7M. Merit Medical Systems, Inc.'s net income of $27.8M is higher than ICU Medical, Inc.'s net income of -$3.4M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 41.50x while ICU Medical, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.33x versus 1.59x for ICU Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Intuitive Surgical, Inc. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of 27.89%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Intuitive Surgical, Inc.'s return on equity of 16.59%.

Merit Medical Systems, Inc. has a consensus price target of $104.00, signalling upside risk potential of 28.25%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $611.82 which suggests that it could grow by 21.34%. Given that Merit Medical Systems, Inc. has higher upside potential than Intuitive Surgical, Inc., analysts believe Merit Medical Systems, Inc. is more attractive than Intuitive Surgical, Inc..

Merit Medical Systems, Inc. has a beta of 0.617, which suggesting that the stock is 38.251% less volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.669, suggesting its more volatile than the S&P 500 by 66.867%.

Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.

Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.9B. Merit Medical Systems, Inc.'s net income of $27.8M is lower than Intuitive Surgical, Inc.'s net income of $799.5M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 41.50x while Intuitive Surgical, Inc.'s PE ratio is 63.98x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.33x versus 18.17x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Insulet Corp. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of 12.4%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Insulet Corp.'s return on equity of 18.92%.

Merit Medical Systems, Inc. has a consensus price target of $104.00, signalling upside risk potential of 28.25%. On the other hand Insulet Corp. has an analysts' consensus of $370.44 which suggests that it could grow by 44.81%. Given that Insulet Corp. has higher upside potential than Merit Medical Systems, Inc., analysts believe Insulet Corp. is more attractive than Merit Medical Systems, Inc..

Merit Medical Systems, Inc. has a beta of 0.617, which suggesting that the stock is 38.251% less volatile than S&P 500. In comparison Insulet Corp. has a beta of 1.400, suggesting its more volatile than the S&P 500 by 39.975%.

Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Insulet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Insulet Corp. pays out -- of its earnings as a dividend.

Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are smaller than Insulet Corp. quarterly revenues of $706.3M. Merit Medical Systems, Inc.'s net income of $27.8M is lower than Insulet Corp.'s net income of $87.6M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 41.50x while Insulet Corp.'s PE ratio is 74.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.33x versus 7.34x for Insulet Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Tandem Diabetes Care, Inc. has a net margin of 7.22% compared to Merit Medical Systems, Inc.'s net margin of -8.49%. Merit Medical Systems, Inc.'s return on equity of 8.28% beat Tandem Diabetes Care, Inc.'s return on equity of -110.24%.

Merit Medical Systems, Inc. has a consensus price target of $104.00, signalling upside risk potential of 28.25%. On the other hand Tandem Diabetes Care, Inc. has an analysts' consensus of $25.95 which suggests that it could grow by 31.34%. Given that Tandem Diabetes Care, Inc. has higher upside potential than Merit Medical Systems, Inc., analysts believe Tandem Diabetes Care, Inc. is more attractive than Merit Medical Systems, Inc..

Merit Medical Systems, Inc. has a beta of 0.617, which suggesting that the stock is 38.251% less volatile than S&P 500. In comparison Tandem Diabetes Care, Inc. has a beta of 1.682, suggesting its more volatile than the S&P 500 by 68.218%.

Merit Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tandem Diabetes Care, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Merit Medical Systems, Inc. pays -- of its earnings as a dividend. Tandem Diabetes Care, Inc. pays out -- of its earnings as a dividend.

Merit Medical Systems, Inc. quarterly revenues are $384.3M, which are larger than Tandem Diabetes Care, Inc. quarterly revenues of $249.3M. Merit Medical Systems, Inc.'s net income of $27.8M is higher than Tandem Diabetes Care, Inc.'s net income of -$21.2M. Notably, Merit Medical Systems, Inc.'s price-to-earnings ratio is 41.50x while Tandem Diabetes Care, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Merit Medical Systems, Inc. is 3.33x versus 1.31x for Tandem Diabetes Care, Inc.. Usually stocks with elevated PS ratios are considered overvalued.